Alan Sandler

Alan Sandler

Director/Board Member at ALX ONCOLOGY HOLDINGS INC.

Net worth: 8 M $ as of 30/05/2026

69 year
Health Technology
Consumer Services
Retail Trade

Profile

Alan Bart Sandler currently works at ALX Oncology Holdings, Inc., as Director from 2025, American Pacific Core, Inc., as President, and Revolution Medicines, Inc., as Chief Development Officer from 2025.
Dr. Sandler also formerly worked at Elevation Oncology, Inc., as Independent Director from 2024 to 2025, Mirati Therapeutics, Inc., as Chief Medical Officer & Executive Vice President from 2022 to 2024, Oregon Health & Science University, as Professor, Chief-Hematology & Oncology, and Zai Lab Ltd., as President, Head-Global Development & Oncology from 2020 to 2022.
Dr. Sandler received his undergraduate degree from the University of Toledo (Ohio) and doctorate degree from Rush Medical College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/03/2026 53,000 ( 0.02% ) 8 M $ 30/05/2026
30/03/2026 0 ( -.--% ) - $ 30/05/2026

Alan Sandler active positions

CompaniesPositionStart
ALX ONCOLOGY HOLDINGS INC. Director/Board Member 16/09/2025
REVOLUTION MEDICINES, INC. Corporate Officer/Principal 28/09/2025
President 29/09/2010

Former positions of Alan Sandler

CompaniesPositionEnd
ELEN ONCO Director/Board Member 22/07/2025
MIRATI THERAPEUTICS Chief Tech/Sci/R&D Officer 31/03/2024
ZAI LAB LIMITED President 27/10/2022
Corporate Officer/Principal -
See the detail of Alan Sandler's experience

Training of Alan Sandler

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

13

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Consumer Services

Retail Trade

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology